Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: findings from the global burden of disease study 2021

疾病负担 疾病 疾病负担 医学 环境卫生 重症监护医学 风险分析(工程) 内科学
作者
Xinpu Han,Zhangjun Yun,Zhu Liu,Yuping Si,Shaodan Tian,Yu Zhang,Yubo Qi,Chengyuan Xue,Meichen Cui,Xu Wen,Yayue Zhang,Li Hou
出处
期刊:Biomedical Engineering Online [BioMed Central]
卷期号:24 (1): 72-72 被引量:25
标识
DOI:10.1186/s12938-025-01403-7
摘要

BACKGROUND: Despite therapeutic advances, acute leukemia (AL) continues to impose a substantial global health burden, with persistently high incidence and mortality rates. Notably, the prediction is that the number of incidence and mortality of acute myeloid leukemia (AML) cases will continue to increase to 184,287.88 and 165,537.59, respectively, by 2040. Using Global Burden of Disease Study (GBD) 2021 data, we assessed the worldwide AL burden from 1990 to 2021, analyzing trends by sex to inform public health strategies. METHODS: To delineate the burden of AL, we reported incidence, prevalence, mortality, and disability-adjusted life year (DALY) rates at global, regional, and national levels, with these estimates including age-standardized rates (ASRs) per 100,000 population and average annual percentage changes (AAPCs) from 1990 to 2021 which were stratified by age, sex, and socio-demographic index (SDI), and computed ASRs and AAPCs using linear regression. Temporal trends were analyzed using an age-period-cohort (APC) model with intrinsic estimation (principal component regression). Risk factor attribution quantified contributions of 21 behavioral, environmental, and metabolic exposures to AL-related DALYs. For inequality assessment, we applied the Slope Index of Inequality and Concentration Index to evaluate absolute and relative disparities in AL burden across regions and countries. Future projections (2040) were modeled via a Bayesian APC framework with Integrated Nested Laplace Approximation. All statistical analyses were performed using R software (version R 4.4.1). The GATHER (Guidelines for Accurate and Transparent Health Estimates Reporting) statement provides a framework to ensure the transparency, reproducibility, and quality of health estimates reporting. RESULTS: Between 1990 and 2021, global ASRs of AL declined, except for acute lymphoblastic leukemia (ALL) age-standardized prevalence rates (ASPR) (AAPC 0.84, 95% CI 0.59-1.10). Case numbers rose overall, though ALL mortality and DALYs decreased. AML burden correlated positively with SDI (ρ > 0, P < 0.001), with the highest number of incident and mortality cases in Western Europe. For ALL, SDI showed positive associations with ASIR and ASPR (ρ > 0, P < 0.001) but negative correlations with ASMR and ASDALR (ρ < 0, P < 0.001), with East Asia being the most severely affected region. High body mass index (BMI), smoking, and benzene/formaldehyde exposure were key AL DALY risk factors. High BMI and smoking predominate in developed countries, and the proportion of DALYs decreases progressively as SDI decreases. Occupational exposures prevailed in developing countries. Population growth drove most absolute increases. Males bore a greater AL burden. AML risk rose with age, whereas ALL displayed bimodal peaks (< 5 and > 40 years). Notably, while ASRs in AL are projected to decline slightly and the number of ALL to decrease by 2040, the number of AML is expected to increase, with the number of incidence and mortality cases increasing by 41.56% and 27.16%, respectively. CONCLUSION: As a major public health concern, despite declining ALL-related mortality and DALYs (1990-2021), AL remains a growing global health challenge, with AML cases projected to rise significantly by 2040. Region-specific intervention strategies are required: high-SDI nations should prioritize smoking cessation and metabolic control to address smoking and high BMI-related AML risks while preparing for aging populations, whereas low/middle-SDI countries urgently need enhanced pediatric ALL diagnosis, treatment capacity, and occupational safety measures. Effective mitigation demands evidence-based health planning, including resource allocation guided by projected AL burden trends and targeted policy interventions to reduce healthcare disparities.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小豆包发布了新的文献求助10
刚刚
个性尔琴发布了新的文献求助10
1秒前
Joy完成签到 ,获得积分10
2秒前
虚幻道罡发布了新的文献求助10
2秒前
小六子发布了新的文献求助10
3秒前
闪闪乘风完成签到 ,获得积分10
3秒前
梦旋发布了新的文献求助50
4秒前
Firsterchao的应助被存亿点好运采纳,获得10
4秒前
林檎发布了新的文献求助10
4秒前
雪糕发布了新的文献求助10
4秒前
超级浩轩发布了新的文献求助10
5秒前
IWC完成签到,获得积分10
5秒前
5秒前
Nole的应助被QY采纳,获得10
6秒前
徐六完成签到,获得积分10
7秒前
852的应助被ppp采纳,获得10
7秒前
YAYA发布了新的文献求助10
8秒前
Nature完成签到,获得积分10
8秒前
molihuakai的应助被xiao采纳,获得10
8秒前
9秒前
鸥羡发布了新的文献求助10
9秒前
10秒前
快乐银耳汤完成签到,获得积分10
10秒前
ding的应助被小豆包采纳,获得10
10秒前
11秒前
12秒前
13秒前
我是老大的应助被Lh采纳,获得10
13秒前
康子浩发布了新的文献求助10
13秒前
13秒前
烟花的应助被烂漫大地采纳,获得10
14秒前
anqi完成签到,获得积分10
15秒前
炸鲜奶发布了新的文献求助10
15秒前
15秒前
15秒前
BingoTang完成签到,获得积分10
15秒前
16秒前
科研通AI2S的应助被xiejiaqing采纳,获得10
16秒前
荔枝烨发布了新的文献求助10
17秒前
秋风的应助被suijinicheng采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163922
求助须知:如何正确求助?哪些是违规求助? 9558007
关于积分的说明 21743214
捐赠科研通 7754605
什么是DOI,文献DOI怎么找? 3428426
关于科研通互助平台的介绍 2553053
邀请新用户注册赠送积分活动 2473048